Assiddiq, B., Tan, K., Toy, W., Chan, S., Chong, P., Lim, Y., & SINGAPORE, C. S. I. O. (2014). EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth.

Assiddiq, B.F., K.Y Tan, W. Toy, S.P Chan, P.K Chong, Y.P Lim, and CANCER SCIENCE INSTITUTE OF SINGAPORE. EGFR S1166 Phosphorylation Induced By a Combination of EGF and Gefitinib Has a Potentially Negative Impact On Lung Cancer Cell Growth. 2014.

Assiddiq, B.F., et al. EGFR S1166 Phosphorylation Induced By a Combination of EGF and Gefitinib Has a Potentially Negative Impact On Lung Cancer Cell Growth. 2014.